NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

氣霧劑療法市場 - 目前分析與預測:2021年∼2027年

Aerosol Therapy Market: Current Analysis and Forecast (2021-2027)

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 1020676
出版日期 內容資訊 英文 108 Pages
商品交期: 最快1-2個工作天內
價格
氣霧劑療法市場 - 目前分析與預測:2021年∼2027年 Aerosol Therapy Market: Current Analysis and Forecast (2021-2027)
出版日期: 2021年07月01日內容資訊: 英文 108 Pages
簡介

氣霧劑療法,是為了直接對肺與其呼吸道投藥所使用的技術。醫療設備,將藥劑轉換為微小的氣霧劑粒子,吸入或直接送入呼吸道和肺。最常使用的吸入藥,是支氣管擴張藥和皮質類固醇。

本報告提供全球氣霧劑療法市場相關調查分析,市場考察,市場動態,主要企業等相關的系統性資訊。

目錄

第1章 市場簡介

第2章 調查手法或前提條件

第3章 業績

第4章 摘要整理

第5章 COVID-19的影響

第6章 市場考察:各產品

  • 乾粉吸入劑
  • 定量吸入器
  • 噴霧器

第7章 市場考察:各適應症

  • 氣喘
  • 慢性阻塞性肺病
  • 囊狀纖維化症
  • 非呼吸系統疾病
    • 糖尿病
    • 止痛
    • 帕金森氏症

第8章 市場考察:各終端用戶

  • 醫院
  • 診所
  • 門診病人手術中心
  • 個人

第9章 市場考察: 各地區

  • 北美的氣霧劑療法市場
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲的氣霧劑療法市場
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他的歐洲
  • 亞太地區的氣霧劑療法市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他的亞太地區
  • 其他地區的氣霧劑療法市場

第10章 相關法規

第11章 需求面分析、供給方面分析

第12章 價值鏈分析

第13章 氣霧劑療法市場趨勢與考察

第14章 氣霧劑療法市場市場動態

  • 促進因素
  • 課題
  • 影響分析
  • 機會

第15章 競爭模式

  • 氣霧劑療法的市場佔有率:各企業

第16章 企業簡介

  • Merck
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • AstraZeneca
  • Novartis
  • Teva Pharmaceuticals
  • Opko Health
  • Omron Healthcare
  • Medtronic
  • GE Healthcare

第17章 免責聲明

目錄
Product Code: UMHE21296

Aerosol therapy is the technique used to administer medication directly into the lungs and its airways. It is usually a suspension of liquids of solids administered using a medical device such as an inhaler. The Medical device converts the medication into fine aerosol particles that can be inhaled or directly propelled into the airway and lungs. The most used inhalation medications are bronchodilators and corticosteroids.

The main respiratory disorders that are currently cured using aerosol therapy include: Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. The novel macromolecular medications are taking aerosol therapy a step further and the therapy is being tested for non-respiratory diseases like diabetes, analgesia, and thyroid as well.

Based on product, the aerosol therapy market can be segmented into dry powder inhalers, metered dose inhalers and nebulizers. These segments can then further be sub segmented into single dose inhalers and multi dose inhalers of dry powder inhalers; conventional pressurized inhalers and soft mist inhalers of metered dose inhalers; and jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers of nebulizers. The nebulizers segment had the highest CAGR in the forecasted period on account of its ability of use in all age groups. In the past few years various types of nebulizers have been introduced. Jet nebulizers are most used in patients with pulmonary diseases as they are bulky and work only with a power source.

Based on application, the aerosol therapy market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases, which include diabetes, analgesia and parkinson's disease. Asthma and COPD are the most treated disorders with aerosol therapy. The asthma segment had the highest CAGR value in the application segment. Asthma is highly prevalent around the world and effect 262 million people in 2019. Asthma is a long-term condition where the air passages in the lungs are partially blocked due to inflammation and muscle tightening. Symptoms of asthma include wheeze, cough, shortness of breath and tightness in chest.

Based on end-user, the aerosol therapy market is segmented into hospitals, clinics, ambulatory surgical centres, and individuals. The most common end-users are hospitals and individuals. The most common end-users are hospitals and individuals. Every year there are approximately 800,000 hospitalizations for Chronic obstructive pulmonary disease (COPD) in the United States which is the third leading cause of death in the country.

For a better understanding of the market adoption of Aerosol Therapy Industry, the market is analysed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Aerosol Therapy market on account of the usage respiratory disorders which are on the rise all over the world.

Some of the major players operating in the market include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, and GE Healthcare. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Objective of the Study
  • 1.3. Limitation
  • 1.4. Stake Holders
  • 1.5. Currency Used in Report
  • 1.6. Scope of the Aerosol Therapy Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Methodology for the Aerosol Therapy Market
    • 2.1.1. Main Objective of the Aerosol Therapy Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

  • 6.1. Dry powder inhalers
    • 6.1.1. Single dose inhalers
    • 6.1.2. Multi dose inhalers
  • 6.2. Metered dose inhalers
    • 6.2.1. Conventional pressurized inhalers
    • 6.2.2. Soft mist inhalers
  • 6.3. Nebulizers
    • 6.3.1. Jet nebulizers
    • 6.3.2. Ultrasonic wave nebulizers
    • 6.3.3. Vibrating mesh nebulizers

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Asthma
  • 7.2. Chronic obstructive pulmonary disease
  • 7.3. Cystic fibrosis
  • 7.4. Non respiratory diseases
    • 7.4.1. Diabetes
    • 7.4.2. Analgesia
    • 7.4.3. Parkinson's disease

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Individual

9 MARKET INSIGHTS BY REGION

  • 9.1. NORTH AMERICA AEROSOL THERAPY MARKET
    • 9.1.1. United States of America
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. EUROPE AEROSOL THERAPY MARKET
    • 9.2.1. United Kingdom
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Spain
    • 9.2.5. Italy
    • 9.2.6. Rest of Europe
  • 9.3. ASIA-PACIFIC AEROSOL THERAPY MARKET
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. Rest of Asia-Pacific
  • 9.4. REST OF THE WORLD AEROSOL THERAPY MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

  • 11.1. Demand Side Analysis
  • 11.2. Supply Side Analysis
    • 11.2.1. Top Product Launches
    • 11.2.2. Top Business Partnerships
    • 11.2.3. Top Business Expansions, Investments and Divestitures
    • 11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 AEROSOL THERAPY MARKET TRENDS & INSIGHTS

14 AEROSOL THERAPY MARKET DYNAMICS

  • 14.1. Drivers
  • 14.2. Challenges
  • 14.3. Impact Analysis
  • 14.4. Opportunity

15 COMPETITIVE SCENARIO

  • 15.1. Aerosol Therapy Market Share, by Company 2020

16 COMPANY PROFILED

  • 16.1. Merck
  • 16.2. Boehringer Ingelheim
  • 16.3. GlaxoSmithKline
  • 16.4. AstraZeneca
  • 16.5. Novartis
  • 16.6. Teva Pharmaceuticals
  • 16.7. Opko Health
  • 16.8. Omron Healthcare
  • 16.9. Medtronic
  • 16.10. GE Healthcare

17 DISCLAIMER